DIA423.85+7.52 1.81%
SPX5,921.54+118.72 2.05%
IXIC19,199.16+461.96 2.47%

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga·06/23/2023 17:37:41
Listen to the news

Gainers

  • Conformis (NASDAQ:CFMS) shares rose 86.2% to $2.16 during Friday's regular session. Trading volume for this security as of 13:37 EST is 5.0 million, which is 7195.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $16.1 million.
  • SCWorx (NASDAQ:WORX) shares moved upwards by 59.05% to $0.57. As of 13:37 EST, this security is trading at a volume of 60.1 million shares, making up 1862.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $7.4 million.
  • OncoSec Medical (NASDAQ:ONCS) stock rose 30.82% to $0.28. As of 13:37 EST, this security is trading at a volume of 45.0 million shares, making up 3523.4% of its average full-day volume over the last 100 days. The company's market cap stands at $1.6 million.
  • Surgalign Holdings (NASDAQ:SRGA) shares moved upwards by 26.99% to $0.26. Surgalign Holdings's stock is trading at a volume of 53.8 million shares as of 13:37 EST. This is 5309.0% of its average full-day volume over the last 100 days. The company's market cap stands at $2.3 million.
  • Etao International Co (NASDAQ:ETAO) shares increased by 23.5% to $0.84. As of 13:37 EST, Etao International Co's stock is trading at a volume of 1.7 million, which is 340.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $85.8 million.
  • Pieris Pharmaceuticals (NASDAQ:PIRS) shares rose 18.54% to $0.26. As of 13:37 EST, Pieris Pharmaceuticals's stock is trading at a volume of 4.8 million, which is 429.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $21.4 million.

Losers

  • Babylon Holdings (NYSE:BBLN) shares decreased by 24.1% to $0.47 during Friday's regular session. Trading volume for this security as of 13:37 EST is 658.0K, which is 96.7% of its average full-day volume over the last 100 days. The company's market cap stands at $12.0 million.
  • Biodexa Pharmaceuticals (NASDAQ:BDRX) shares decreased by 20.38% to $0.06. Biodexa Pharmaceuticals's stock is trading at a volume of 6.2 million shares as of 13:37 EST. This is 123.6% of its average full-day volume over the last 100 days. The company's market cap stands at $1.1 million.
  • Beyond Air (NASDAQ:XAIR) shares declined by 19.37% to $4.6. As of 13:37 EST, Beyond Air's stock is trading at a volume of 2.1 million, which is 598.7% of its average full-day volume over the last 100 days. The company's market cap stands at $138.4 million. As per the press release, Q4 earnings came out yesterday.
  • Stoke Therapeutics (NASDAQ:STOK) stock decreased by 15.31% to $11.12. As of 13:37 EST, Stoke Therapeutics's stock is trading at a volume of 181.6K, which is 76.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $491.3 million.
  • Oramed Pharmaceuticals (NASDAQ:ORMP) shares fell 14.81% to $3.19. As of 13:37 EST, Oramed Pharmaceuticals's stock is trading at a volume of 745.5K, which is 82.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $127.8 million.
  • Benitec Biopharma (NASDAQ:BNTC) shares decreased by 14.57% to $0.19. The current volume of 540.0K shares is 177.9% of Benitec Biopharma's average full-day volume over the last 100 days (last updated at 13:37 EST). The market value of their outstanding shares is at $5.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.